In January 2015, the Society of Thoracic Surgeons (STS) began the voluntary public reporting of outcomes achieved by participating congenital cardiac surgery programs. Not surprisingly, this information has attracted considerable attention from the media as well as parent support groups and hospital administrators. Programs that did not report were strongly criticized by some and accused of possibly concealing less than ideal outcomes. However, a few programs that had signed a consent agreement to participate in public reporting were surprised to find that their data had not been reported due to incomplete data. Additional programs were surprised to find that their star rating was less than anticipated despite having achieved equal or better outcomes relative to those of the STS aggregate outcome data described in the comprehensive blinded feedback reports that they receive twice a year from the STS. The explanation for these surprises can be found in the article by Jacobs and Jacobs in this issue of The World Journal for Pediatric and Congenital Heart Surgery titled ''Transparency and Public Reporting of Pediatric and Congenital Heart Surgery Outcomes in North America.'' Evolving Sophistication of Risk Adjustment by the STS Jacobs and Jacobs explain that the earliest attempts to assess and adjust for a center's case mix used subjective estimates of case complexity developed by a group of senior congenital cardiac surgeons. As the North American STS and European Association for Cardio-Thoracic Surgery (EACTS)/European Congenital Heart Surgeons Association (ECHSA) databases accumulated an increasing number of cases, it became possible to use a more data-driven method for determining the risk of mortality according to the primary procedure of the operation. In 2010, both databases changed their primary method of adjustment for case mix from the Risk-Adjustment for Congenital Heart Surgery 1 (RACHS-1) and Aristotle methods to the empirically based STAT method of stratification. This system is essentially case stratification that is primarily based on the risk of mortality of the primary procedure of the operation using statistical estimates that are based on an enormous body of objective data collected in both North American and European congenital heart surgery databases over a period of several years. It allows ''apples to be compared with apples'' from one program to the aggregate of all participating programs using five broad categories.
Limitation of the STAT Mortality Categories
The most obvious limitation of the STAT mortality categories is the relatively small number of cases at many centers within some categories such as the most complex category 5. In addition, there is no direct adjustment for noncardiac factors such as prematurity and important noncardiac congenital abnormalities such as tracheoesophageal fistula that have been documented by many studies to have a powerful influence on outcome. A midsize to small program that is unfortunate enough to have a run of more very tiny premature babies with serious associated noncardiac anomalies than the average program may find that their outcomes are heavily swayed by deaths among these patients. Although adult cardiac programs that are generally much larger than pediatric programs have sufficient numbers from year to year to smooth out the influence of a few high-risk cases that are not defined solely by the primary procedure of the operation, this situation is not true when comparing the majority of pediatric programs.
Refinement of Risk Adjustment
In 2014, the STS risk adjustment model was augmented for the first time to include a variety of noncardiac factors including prematurity, weight, noncardiac congenital abnormalities, and various preoperative factors such as preoperative mechanical ventilation or shock. As described by Jacobs and Jacobs, this more sophisticated method of risk adjustment allows for calculation of an observed-to-expected mortality ratio. Centers for which the 95% confidence interval for their risk-adjusted observed-to-expected operative mortality ratio is entirely above the number 1 or entirely below the number 1 are identified as having higher than expected or lower than expected operative mortality, respectively, and are classified as one star programs or three star programs. Centers whose 95% confidence interval for their riskadjusted observed-to-expected operative mortality ratio overlaps with the number 1 are identified as having same as expected operative mortality and are classified as two star programs.
The Importance of Complete Data
In order to be sure that all centers could have their outcomes adjusted appropriately for all of the preoperative factors and related data fields that are relevant to the mortality risk model, STS requires a threshold level of data completeness as a condition of eligibility for reporting of risk-adjusted outcomes utilizing the new comprehensive risk model. This requirement perhaps surprised many centers. Failure to enter more than 90% of the data in the fields included in the new risk model was the reason that a few centers that had agreed to public reporting did not have data appear on the public reporting Web site of the STS.
The Importance of Accurate Preoperative Data
Failure to accurately scrutinize a patient's preoperative status can lead to a patient being coded as having no associated anomalies or preoperative risk factors. If a patient is coded as having no preoperative risk factors, then the expected mortality is likely to be low, and even a highly commendable low observed rate of morality may nevertheless result in an observed-to-expected ratio that falls into the range classified as one star.
Going Forward
The present level of risk adjustment needs further refinement, for example, the current yes/no field for ''any noncardiac congenital anatomic abnormality'' fails to distinguish between the highly important impact of a serious anomaly such as diaphragmatic hernia or tracheoesophageal fistula by awarding equal weight to minor anomalies such as cleft lip. In addition, a rolling average of the previous 4 years' data will help smooth the impact of a cluster of high-risk cases. A greater level of granularity will undoubtedly require even more effort and expense in data management for congenital cardiac surgery programs. However, in a new era of transparency, hospital administrators will need to accept the fact that this effort and expenditure is going to be a cost of doing business. Failure to do so could result in embarrassment for the cardiac surgical team, their hospital, and its administrators. On the other hand, complete and accurate data submission by all congenital cardiac programs will enhance an already powerful tool for outcome assessment and quality improvement, enabling us to refine and improve outcomes for our patients.
